CGEM Competitors & Alternatives
Compare Cullinan Therapeutics, Inc. Common Stock with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CGEM
Main Stock$13.73
Tradestie Score
54
Market Cap
$354.45M
Analyst Upside
+128.4%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$346.37
|
$160.70B | 24.8 | 54 | Compare |
|
GILD
Gilead Sciences Inc
|
$139.23
|
$137.92B | 20.6 | 60 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$740.75
|
$46.96B | 37.3 | 56 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$90.03
|
$24.57B | - | 58 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$176.92
|
$22.61B | 20.8 | 55 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$130.37
|
$13.59B | 28.2 | 63 | Compare |
|
EXEL
Exelixis Inc
|
$43.50
|
$11.09B | 15.8 | 64 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$48.80
|
$10.74B | - | 57 | Compare |
|
QGEN
QIAGEN N.V.
|
$40.79
|
$10.04B | 19.6 | 63 | Compare |
|
TECH
Bio-Techne Corp.
|
$52.98
|
$9.33B | 98.6 | 59 | Compare |
More CGEM Analysis
Data updated: Apr 02, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry